BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer. (2018)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-17-2259
PubMed Identifier: 29420220
Publication URI: http://europepmc.org/abstract/MED/29420220
Type: Journal Article/Review
Volume: 24
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 15
ISSN: 1078-0432